Angion Biomedica Corp. (ANGN) Stock on a Constant Decline, Here’s the Reason
Angion Biomedica Corp. (ANGN), a biopharmaceutical company, has plunged 56.73% in aftermarket trading session and is currently trading at $3.76. The dip could be attributed